Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × venetoclax × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 176 Leukemia, Lymphocytic, Chronic, B-Cell 61 Myelodysplastic Syndromes 45 Recurrence 28 Leukemia 28 Precursor Cell Lymphoblastic Leukemia-Lymphoma 25 Leukemia, Myelomonocytic, Chronic 21 Lymphoma, Mantle-Cell 18 Lymphoma, Non-Hodgkin 16 Burkitt Lymphoma 13 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 12 Lymphoma 12 Leukemia, Biphenotypic, Acute 12 Hematologic Neoplasms 12 Lymphoma, B-Cell, Marginal Zone 11 Lymphoma, Large B-Cell, Diffuse 10 Neoplasms 9 Multiple Myeloma 9 Lymphoma, Follicular 9 Myeloproliferative Disorders 8 Waldenstrom Macroglobulinemia 7 Neoplasm, Residual 6 Lymphoma, B-Cell 6 Blastic Plasmacytoid Dendritic Cell Neoplasm 5 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 GATA2 Deficiency 4 Leukemia, Myeloid 3 Immunoglobulin Light-chain Amyloidosis 3 Anemia, Refractory, with Excess of Blasts 3

Interventions

pembrolizumab 16 Nivolumab 12 avelumab 8 Ipilimumab 6 Specimen Handling 5 Biopsy 5 atezolizumab 4 Magnetic Resonance Spectroscopy 4 cemiplimab 3 Cyclophosphamide 3 poly ICLC 2 fludarabine phosphate 2 fludarabine 2 aldesleukin 2 Radiotherapy 2 Radiosurgery 2 Interleukin-2 2 Immunoglobulin G 2 Docetaxel 2 Bevacizumab 2 tocilizumab 1 talimogene laherparepvec 1 sargramostim 1 relatlimab 1 regorafenib 1 prednylidene 1 lutetium Lu 177 dotatate 1 lenvatinib 1 flt3 ligand protein 1 efineptakin alfa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡